Zituvimet (sitagliptin/metformin) – New drug approval
November 3, 2023 - The FDA approved Zydus Pharmaceuticals’ Zituvimet (sitagliptin/metformin), as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus (T2DM).
Download PDF
